Pegylated synthetic human c-peptide
Modify Date: 2024-01-03 14:08:54
Pegylated synthetic human c-peptide structure
|
Common Name | Pegylated synthetic human c-peptide | ||
|---|---|---|---|---|
| CAS Number | 1350661-05-0 | Molecular Weight | 3018.52 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C129H211N35O48 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Pegylated synthetic human c-peptidePegylated synthetic human c-peptide retains bioactivity comparable to that of natural (i.e. non-polyethylene glycolated) C-peptides and has a prolonged circulating residence time in plasma for use in diabetic peripheral neuropathy studies[1]. |
| Name | Pegylated synthetic human c-peptide |
|---|
| Description | Pegylated synthetic human c-peptide retains bioactivity comparable to that of natural (i.e. non-polyethylene glycolated) C-peptides and has a prolonged circulating residence time in plasma for use in diabetic peripheral neuropathy studies[1]. |
|---|---|
| Related Catalog | |
| In Vivo | Pegylated synthetic human c-peptide (CBX129801) (s.c., 0.4, 1.33 or 4.0 mg/kg/wk, 39 weeks) 可以导致给药后注射部位组织中空泡化巨噬细胞的细胞质浸润和引流腋窝淋巴结，而不会导致全身巨噬细胞空泡化[1]。 |
| References |
| Molecular Formula | C129H211N35O48 |
|---|---|
| Molecular Weight | 3018.52 |